Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel Free AMPX Stock Alerts

Amprius Technologies (AMPX) Financials

Amprius Technologies logo
$9.90 +0.27 (+2.80%)
As of 03:58 PM Eastern
Compare
Annual Income Statements for Amprius Technologies

Annual Income Statements for Amprius Technologies

This table shows Amprius Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -9.90 -17 -37 -45 -44
Consolidated Net Income / (Loss)		 -9.90 -17 -37 -45 -44
Net Income / (Loss) Continuing Operations		 -9.90 -17 -37 -45 -44
Total Pre-Tax Income 		-9.90 -17 -37 -45 -44
Total Operating Income		 -11 -18 -39 -46 -47
Total Gross Profit		 -4.33 -5.65 -15 -18 8.26
Total Revenue		 2.77 4.41 9.05 24 73
Operating Revenue		 2.77 4.41 9.05 24 73
Total Cost of Revenue		 7.10 10 24 42 65
Operating Cost of Revenue		 7.10 10 24 42 65
Total Operating Expenses		 6.29 12 24 28 55
Selling, General & Admin Expense		 4.84 10 20 19 23
Research & Development Expense		 1.45 2.03 3.68 7.34 9.43
Restructuring Charge		 - - - 1.86 23
Total Other Income / (Expense), net		 0.73 0.71 1.93 1.59 2.62
Interest & Investment Income		 -0.02 0.71 2.51 1.59 2.62
Basic Earnings per Share		 ($0.15) ($0.24) ($0.43) ($0.45) ($0.35)
Weighted Average Basic Shares Outstanding		 65.76M 71.34M 86.20M 101.87M 124.64M
Diluted Earnings per Share		 ($0.15) ($0.24) ($0.43) ($0.45) ($0.35)
Weighted Average Diluted Shares Outstanding		 65.76M 71.34M 86.20M 101.87M 124.64M
Weighted Average Basic & Diluted Shares Outstanding		 - 84.63M 91.60M 117.93M 137.02M

Quarterly Income Statements for Amprius Technologies

This table shows Amprius Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -9.73 -9.89 -13 -11 -11 -9.37 -6.37 -3.89 -24 -5.05 -5.08
Consolidated Net Income / (Loss)		 -9.73 -9.89 -13 -11 -11 -9.37 -6.37 -3.89 -24 -5.05 -3.15
Net Income / (Loss) Continuing Operations		 -9.73 -9.89 -13 -11 -11 -9.37 -6.37 -3.89 -24 -5.05 -3.15
Total Pre-Tax Income 		-9.73 -9.89 -13 -11 -11 -9.37 -6.37 -3.89 -24 -5.05 -4.30
Total Operating Income		 -9.74 -10 -13 -11 -12 -9.67 -6.81 -4.69 -25 -6.69 -4.30
Total Gross Profit		 -3.88 -4.45 -6.53 -5.10 -2.25 -2.36 1.34 3.32 5.97 5.74 9.28
Total Revenue		 3.94 2.34 3.35 7.86 11 11 15 21 25 29 34
Operating Revenue		 3.94 2.34 3.35 7.86 11 11 15 21 25 29 34
Total Cost of Revenue		 7.82 6.78 9.88 13 13 14 14 18 19 23 25
Operating Cost of Revenue		 7.82 6.78 9.88 13 13 14 14 18 19 23 25
Total Operating Expenses		 5.87 5.87 6.40 6.15 9.51 7.31 8.15 8.01 31 12 14
Selling, General & Admin Expense		 4.58 4.29 4.74 4.34 5.36 5.31 5.99 5.50 6.16 8.63 9.48
Research & Development Expense		 1.29 1.58 1.66 1.82 2.28 2.00 2.16 2.51 2.76 3.80 4.10
Total Other Income / (Expense), net		 0.01 0.43 0.42 0.40 0.34 0.30 0.44 0.80 1.08 1.64 0.00
Other Gains / (Losses), net		 - - - - - - - - - - 1.14
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 - - - - - - - - - - 1.92
Basic Earnings per Share		 ($0.11) ($0.11) ($0.13) ($0.10) ($0.11) ($0.08) ($0.05) ($0.03) ($0.19) ($0.04) ($0.04)
Weighted Average Basic Shares Outstanding		 86.20M 90.03M 97.05M 110.41M 101.87M 117.97M 121.78M 126.63M 124.64M 136.95M 143.47M
Diluted Earnings per Share		 ($0.11) ($0.11) ($0.13) ($0.10) ($0.11) ($0.08) ($0.05) ($0.03) ($0.19) ($0.04) ($0.04)
Weighted Average Diluted Shares Outstanding		 86.20M 90.03M 97.05M 110.41M 101.87M 117.97M 121.78M 126.63M 124.64M 136.95M 143.47M
Weighted Average Basic & Diluted Shares Outstanding		 91.60M 94.47M 111.05M 105.84M 117.93M 120.55M 125.08M 130.48M 137.02M 141.63M 146.08M

Annual Cash Flow Statements for Amprius Technologies

This table details how cash moves in and out of Amprius Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 11 58 -24 11 36
Net Cash From Operating Activities		 -8.02 -14 -26 -33 -31
Net Cash From Continuing Operating Activities		 -8.02 -14 -26 -33 -31
Net Income / (Loss) Continuing Operations		 -9.90 -17 -37 -45 -44
Consolidated Net Income / (Loss)		 -9.90 -17 -37 -45 -44
Depreciation Expense		 1.44 1.54 1.81 3.81 4.37
Amortization Expense		 0.55 1.59 3.06 6.39 5.14
Non-Cash Adjustments To Reconcile Net Income		 1.89 3.27 5.61 9.21 30
Changes in Operating Assets and Liabilities, net		 -2.00 -2.94 0.75 -8.08 -27
Net Cash From Investing Activities		 -0.61 -1.48 -18 -3.21 -4.40
Net Cash From Continuing Investing Activities		 -0.61 -1.48 -18 -3.21 -4.40
Purchase of Property, Plant & Equipment		 -0.61 -1.48 -18 -3.21 -4.40
Net Cash From Financing Activities		 20 74 19 47 71
Net Cash From Continuing Financing Activities		 20 74 19 47 71
Repurchase of Common Equity		 0.00 -0.33 -0.60 -0.76 0.00
Issuance of Common Equity		 0.00 78 19 33 64
Other Financing Activities, net		 20 -3.93 0.31 14 7.37
Effect of Exchange Rate Changes		 - - - 0.00 0.00

Quarterly Cash Flow Statements for Amprius Technologies

This table details how cash moves in and out of Amprius Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 -7.64 -5.52 7.40 -11 20 -6.53 5.78 19 17 -29 12
Net Cash From Operating Activities		 -4.80 -9.78 -7.96 -9.53 -6.09 -14 -4.27 -9.25 -3.50 -37 -2.85
Net Cash From Continuing Operating Activities		 -4.80 -9.78 -7.96 -9.53 -6.09 -14 -4.27 -9.25 -3.50 -37 -2.85
Net Income / (Loss) Continuing Operations		 -9.73 -9.89 -13 -11 -11 -9.37 -6.37 -3.89 -24 -5.05 -3.15
Consolidated Net Income / (Loss)		 -9.73 -9.89 -13 -11 -11 -9.37 -6.37 -3.89 -24 -5.05 -3.15
Depreciation Expense		 0.49 1.02 1.04 0.86 0.89 0.94 1.02 1.18 1.22 0.76 0.75
Amortization Expense		 1.18 1.29 - 5.10 1.29 1.29 1.29 1.29 1.29 0.62 0.31
Non-Cash Adjustments To Reconcile Net Income		 2.84 1.25 3.23 -0.85 4.30 2.10 2.45 1.39 24 1.76 2.54
Changes in Operating Assets and Liabilities, net		 0.43 -3.44 0.30 -3.80 -1.14 -9.08 -2.65 -9.21 -6.07 -36 -3.30
Net Cash From Investing Activities		 -5.75 -3.90 -1.61 -1.33 3.63 -0.91 -0.72 -0.41 -2.36 -0.63 -1.82
Net Cash From Continuing Investing Activities		 -5.75 -3.90 -1.61 -1.33 3.63 -0.91 -0.72 -0.41 -2.36 -0.63 -1.82
Purchase of Property, Plant & Equipment		 -5.75 -3.90 -1.61 -1.33 3.63 -0.91 -0.72 -0.41 -2.36 -0.98 -1.82
Net Cash From Financing Activities		 2.92 8.16 17 -0.54 23 8.51 11 29 23 8.58 17
Net Cash From Continuing Financing Activities		 2.92 8.16 17 -0.54 23 8.51 11 29 23 8.58 17
Other Financing Activities, net		 0.20 0.03 14 - 0.01 0.05 1.02 2.83 3.47 8.58 17
Effect of Exchange Rate Changes		 - 0.00 - - - -0.00 -0.00 0.00 0.01 0.01 0.01

Annual Balance Sheets for Amprius Technologies

This table presents Amprius Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 19 83 108 121 157
Total Current Assets		 14 75 51 69 126
Cash & Equivalents		 11 70 46 55 90
Accounts Receivable		 0.26 0.69 1.27 5.58 24
Inventories, net		 0.50 0.50 0.73 6.57 6.74
Prepaid Expenses		 0.16 2.39 1.99 1.45 5.50
Plant, Property, & Equipment, net		 4.21 4.24 22 17 9.68
Total Noncurrent Assets		 0.14 3.76 35 35 21
Other Noncurrent Operating Assets		 0.14 3.76 35 35 21
Total Liabilities & Shareholders' Equity		 19 83 108 121 157
Total Liabilities		 4.67 10 48 52 53
Total Current Liabilities		 4.17 6.92 13 17 18
Accounts Payable		 1.81 3.74 8.94 12 10
Current Deferred Revenue		 2.36 2.66 3.43 1.64 2.84
Other Current Liabilities		 0.00 0.52 1.09 3.32 4.67
Total Noncurrent Liabilities		 0.50 3.22 34 34 35
Other Noncurrent Operating Liabilities		 0.00 2.50 34 34 35
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 14 73 60 69 104
Total Preferred & Common Equity		 14 73 60 69 104
Preferred Stock		 - 0.00 0.00 0.00 0.00
Total Common Equity		 14 73 60 69 104
Common Stock		 89 166 189 244 322
Retained Earnings		 -75 -93 -130 -174 -218
Accumulated Other Comprehensive Income / (Loss)		 - - - 0.00 0.00

Quarterly Balance Sheets for Amprius Technologies

This table presents Amprius Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 84 87 87 105 113 104 118 123 156 131 149
Total Current Assets		 70 71 61 46 53 45 66 72 107 114 132
Cash & Equivalents		 64 65 53 39 46 35 48 54 73 62 75
Accounts Receivable		 0.56 1.13 1.89 1.44 1.74 4.59 10 11 22 35 41
Inventories, net		 0.85 0.50 0.49 0.86 1.53 2.66 4.00 4.34 4.68 8.25 12
Prepaid Expenses		 1.84 1.48 2.74 3.35 2.17 2.64 3.31 2.56 6.88 8.10 4.91
Plant, Property, & Equipment, net		 4.95 6.90 17 23 24 24 18 17 16 11 12
Total Noncurrent Assets		 9.10 9.03 8.55 36 36 35 34 34 33 6.08 5.89
Other Noncurrent Operating Assets		 9.10 9.03 8.55 36 36 35 34 34 33 6.08 5.89
Total Liabilities & Shareholders' Equity		 84 87 87 105 113 104 118 123 156 131 149
Total Liabilities		 17 20 21 45 48 48 48 46 53 21 24
Total Current Liabilities		 8.88 12 14 9.76 13 13 14 12 16 16 18
Accounts Payable		 4.69 7.74 9.23 5.42 7.76 9.13 8.55 7.81 12 12 14
Current Deferred Revenue		 3.14 3.20 3.57 3.24 3.15 1.82 1.78 0.84 0.71 2.76 3.15
Other Current Liabilities		 1.06 1.07 1.08 1.10 1.92 2.05 3.64 3.43 3.22 1.17 1.18
Total Noncurrent Liabilities		 8.03 7.94 6.98 35 35 35 34 34 37 5.39 5.20
Other Noncurrent Operating Liabilities		 7.13 7.00 6.87 35 35 35 34 34 37 5.39 5.20
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 67 67 66 60 65 56 70 77 103 109 126
Total Preferred & Common Equity		 67 67 66 60 65 56 70 77 103 109 126
Preferred Stock		 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 67 67 66 60 65 56 70 77 103 109 126
Common Stock		 169 178 186 199 217 219 254 267 297 333 352
Retained Earnings		 -102 -111 -120 -140 -152 -163 -184 -190 -194 -223 -227
Accumulated Other Comprehensive Income / (Loss)		 - - - - - - -0.00 -0.01 -0.00 0.01 0.02

Annual Metrics And Ratios for Amprius Technologies

This table displays calculated financial ratios and metrics derived from Amprius Technologies' official financial filings.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 - - - - 130,483,838.00
DEI Adjusted Shares Outstanding		 - - - - 130,483,838.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - -0.34
Growth Metrics		 - - - - -
Profitability Metrics		 - - - - -
Net Operating Profit after Tax (NOPAT)		 -7.44 -13 -27 -32 -33
Return On Investment Capital (ROIC_SIMPLE)		 - - -45.31% -46.61% -31.45%
Earnings before Interest and Taxes (EBIT)		 -11 -18 -39 -46 -47
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -8.63 -15 -34 -36 -37
Valuation Ratios		 - - - - -
Leverage & Solvency		 - - - - -
Liquidity Ratios		 - - - - -
Cash Flow Metrics		 - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -14 -38 -33 -32
Efficiency Ratios		 - - - - -
Capital & Investment Metrics		 - - - - -
Invested Capital		 2.37 3.34 14 14 13
Increase / (Decrease) in Invested Capital		 0.00 0.97 11 0.28 -0.97
Book Value per Share		 $0.21 $0.86 $0.68 $0.66 $0.80
Tangible Book Value per Share		 $0.21 $0.86 $0.68 $0.66 $0.80
Total Capital		 14 73 60 69 104
Total Debt		 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00
Net Debt		 -11 -70 -46 -55 -90
Capital Expenditures (CapEx)		 0.61 1.48 18 3.21 4.40
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -1.48 -1.44 -8.70 -3.60 18
Debt-free Net Working Capital (DFNWC)		 10 68 37 52 109
Net Working Capital (NWC)		 10 68 37 52 109
Net Nonoperating Expense (NNE)		 2.46 4.70 9.68 12 11
Net Nonoperating Obligations (NNO)		 -11 -70 -46 -55 -90
Total Depreciation and Amortization (D&A)		 1.99 3.12 4.86 10 9.51
Earnings Adjustments		 - - - - -
Adjusted Basic Earnings per Share		 $0.00 ($0.24) ($0.43) ($0.45) ($0.35)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 71.34M 86.20M 101.87M 124.64M
Adjusted Diluted Earnings per Share		 $0.00 ($0.24) ($0.43) ($0.45) ($0.35)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 71.34M 86.20M 101.87M 124.64M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 84.63M 91.60M 117.93M 137.02M
Normalized Net Operating Profit after Tax (NOPAT)		 -7.44 -13 -27 -31 -17
Debt Service Ratios		 - - - - -
Payout Ratios		 - - - - -

Quarterly Metrics And Ratios for Amprius Technologies

This table displays calculated financial ratios and metrics derived from Amprius Technologies' official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 - - - - - - - - 130,483,838.00 137,019,004.00 141,627,170.00
DEI Adjusted Shares Outstanding		 - - - - - - - - 130,483,838.00 137,019,004.00 141,627,170.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - -0.19 -0.04 -0.04
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 397.98% 244.04% 104.96% 180.74% 169.55% 383.05% 350.43% 172.77% - 152.89% 125.87%
EBITDA Growth		 -29.32% -3.37% -24.21% 26.48% -18.58% 7.16% 57.50% 81.01% - 28.69% 28.20%
EBIT Growth		 -46.59% -5.83% -28.26% -23.24% -20.67% 6.28% 47.32% 58.30% - 30.86% 36.91%
NOPAT Growth		 -46.59% -5.83% -28.26% -23.24% -20.67% 6.28% 47.32% 58.30% - 30.86% 36.91%
Net Income Growth		 -60.73% -8.61% -32.48% -27.77% -17.30% 5.21% 49.11% 64.13% - 46.15% 50.49%
EPS Growth		 -37.50% 0.00% -18.18% 0.00% 0.00% 27.27% 61.54% 70.00% - 50.00% 20.00%
Operating Cash Flow Growth		 15.76% -50.63% -42.56% -9.81% -26.77% -44.45% 46.41% 2.97% - -163.88% 33.15%
Free Cash Flow Firm Growth		 0.00% -112.85% -112.94% 0.49% 51.44% 68.90% 67.18% 25.33% - -278.74% -270.23%
Invested Capital Growth		 320.71% 633.50% 1,012.02% 69.53% 1.98% 5.21% 20.25% 43.02% - 114.12% 127.55%
Revenue Q/Q Growth		 40.96% -40.77% 43.19% 134.83% 35.34% 6.14% 33.53% 42.20% - 13.09% 19.26%
EBITDA Q/Q Growth		 -12.38% -27.97% -27.89% 55.56% -81.25% 22.33% 39.40% 50.67% - 76.89% 38.99%
EBIT Q/Q Growth		 -6.71% -5.90% -25.32% 12.98% -4.49% 17.75% 29.55% 31.13% - 73.75% 35.73%
NOPAT Q/Q Growth		 -6.71% -5.90% -25.32% 12.98% -4.49% 17.75% 29.55% 31.13% - 73.75% 35.73%
Net Income Q/Q Growth		 -14.63% -1.56% -26.61% 13.32% -5.24% 17.93% 32.02% 38.90% - 79.31% 37.50%
EPS Q/Q Growth		 -10.00% 0.00% -18.18% 23.08% -10.00% 27.27% 37.50% 40.00% - 78.95% 0.00%
Operating Cash Flow Q/Q Growth		 44.69% -103.73% 18.61% -19.73% 36.14% -132.14% 69.81% -116.79% - -965.91% 92.35%
Free Cash Flow Firm Q/Q Growth		 -5.86% -44.19% -3.12% 36.78% 48.34% 7.64% -8.82% -43.81% - -76.51% -6.38%
Invested Capital Q/Q Growth		 13.58% 48.80% -10.57% 12.16% -31.67% 53.52% 2.21% 33.40% - 252.52% 8.62%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 -98.35% -190.28% -195.25% -64.94% -21.19% -20.92% 8.89% 15.49% - 20.11% 27.27%
EBITDA Margin		 -204.87% -398.20% -355.64% -67.29% -90.12% -65.95% -29.93% -10.38% - -18.60% -9.51%
Operating Margin		 -247.06% -441.74% -386.61% -143.26% -110.60% -85.71% -45.22% -21.90% - -23.43% -12.63%
EBIT Margin		 -247.06% -441.74% -386.61% -143.26% -110.60% -85.71% -45.22% -21.90% - -23.43% -12.63%
Profit (Net Income) Margin		 -246.81% -423.20% -374.20% -138.13% -107.40% -83.05% -42.28% -18.16% - -17.68% -9.27%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% - 100.00% 73.38%
Interest Burden Percent		 99.90% 95.80% 96.79% 96.42% 97.11% 96.90% 93.50% 82.95% - 75.46% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Return on Invested Capital (ROIC)		 -180.21% -279.02% -330.22% -105.24% -131.97% -92.69% -68.98% -35.17% - -42.89% -26.25%
ROIC Less NNEP Spread (ROIC-NNEP)		 -175.16% -273.86% -324.00% -98.51% -125.65% -86.74% -65.80% -34.04% - -42.23% -26.02%
Return on Net Nonoperating Assets (RNNOA)		 152.25% 222.66% 273.95% 71.56% 98.09% 58.21% 46.70% 23.15% - 26.02% 16.55%
Return on Equity (ROE)		 -27.96% -56.36% -56.27% -33.68% -33.88% -34.48% -22.28% -12.01% - -16.87% -9.69%
Cash Return on Invested Capital (CROIC)		 -435.06% -383.65% -456.64% -237.54% -230.37% -154.05% -152.77% -125.95% - -161.20% -156.17%
Operating Return on Assets (OROA)		 -23.43% -50.16% -48.17% -26.25% -23.36% -25.44% -17.20% -9.81% - -16.97% -10.13%
Return on Assets (ROA)		 -23.41% -48.06% -46.63% -25.31% -22.68% -24.65% -16.08% -8.14% - -12.81% -7.44%
Return on Common Equity (ROCE)		 -27.96% -56.36% -56.27% -33.68% -33.88% -34.48% -22.28% -12.01% - -16.87% -9.69%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -62.67% -62.38% -76.76% 0.00% -62.73% 0.00% 0.00% - 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -6.82 -7.22 -9.05 -7.88 -8.23 -6.77 -4.77 -3.28 -18 -4.68 -3.01
NOPAT Margin		 -172.94% -309.22% -270.62% -100.28% -77.42% -59.99% -31.65% -15.33% - -16.40% -8.84%
Net Nonoperating Expense Percent (NNEP)		 -5.05% -5.16% -6.22% -6.72% -6.32% -5.95% -3.18% -1.12% - -0.66% -0.23%
Return On Investment Capital (ROIC_SIMPLE)		 -11.41% - - - -11.85% -9.62% -6.22% -3.18% -17.17% -4.28% -2.39%
Cost of Revenue to Revenue		 198.35% 290.28% 295.25% 164.94% 121.19% 120.92% 91.11% 84.51% - 79.89% 72.73%
SG&A Expenses to Revenue		 116.00% 183.78% 141.67% 55.19% 50.41% 47.03% 39.76% 25.67% - 30.24% 27.85%
R&D to Revenue		 32.71% 67.68% 49.69% 23.13% 21.48% 17.75% 14.35% 11.71% - 13.31% 12.04%
Operating Expenses to Revenue		 148.71% 251.46% 191.36% 78.32% 89.41% 64.78% 54.11% 37.38% - 43.55% 39.90%
Earnings before Interest and Taxes (EBIT)		 -9.74 -10 -13 -11 -12 -9.67 -6.81 -4.69 -25 -6.69 -4.30
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -8.08 -9.30 -12 -5.29 -9.58 -7.44 -4.51 -2.23 -23 -5.31 -3.24
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 7.82 4.05 1.84 2.20 4.27 4.49 6.62 12.75 - 21.11 15.62
Price to Tangible Book Value (P/TBV)		 7.82 4.05 1.84 2.20 4.27 4.49 6.62 12.75 - 21.11 15.62
Price to Revenue (P/Rev)		 51.65 22.66 9.66 7.05 12.26 9.54 11.32 22.53 - 25.59 17.97
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 30.05 9.75 3.94 4.21 16.85 12.18 20.18 41.46 - 47.76 36.94
Enterprise Value to Revenue (EV/Rev)		 46.60 19.02 5.92 5.05 9.98 8.08 10.11 21.27 - 24.90 17.29
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Financial Leverage		 -0.87 -0.81 -0.85 -0.73 -0.78 -0.67 -0.71 -0.68 - -0.62 -0.64
Leverage Ratio		 1.44 1.49 1.51 1.57 1.77 1.71 1.66 1.64 - 1.39 1.35
Compound Leverage Factor		 1.44 1.42 1.46 1.51 1.72 1.66 1.56 1.36 - 1.05 1.35
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% - 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Altman Z-Score		 4.37 1.58 -0.22 -0.48 1.82 2.31 5.17 14.05 - 63.89 49.44
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.75 4.67 4.14 3.46 4.00 4.74 5.95 6.65 - 7.13 7.17
Quick Ratio		 3.49 4.15 3.76 3.05 3.53 4.21 5.38 5.93 - 6.11 6.28
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -18 -25 -26 -16 -8.51 -7.86 -8.55 -12 -17 -30 -32
Operating Cash Flow to CapEx		 -83.46% -251.00% -495.89% -714.85% 0.00% -1,547.21% -595.67% -2,233.33% - -5,964.00% -156.73%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.09 0.11 0.12 0.18 0.21 0.30 0.38 0.45 - 0.72 0.80
Accounts Receivable Turnover		 9.28 10.73 8.66 5.40 7.06 5.59 7.17 4.41 - 3.95 4.25
Inventory Turnover		 38.58 30.90 31.06 23.76 11.64 20.31 18.15 15.90 - 12.07 10.72
Fixed Asset Turnover		 0.70 0.77 0.81 0.86 1.23 1.62 2.18 2.90 - 6.29 7.54
Accounts Payable Turnover		 3.75 5.21 4.07 4.08 4.01 7.07 6.83 5.49 - 7.18 7.78
Days Sales Outstanding (DSO)		 39.33 34.03 42.13 67.62 51.69 65.24 50.90 82.82 - 92.31 85.91
Days Inventory Outstanding (DIO)		 9.46 11.81 11.75 15.36 31.37 17.97 20.10 22.96 - 30.25 34.05
Days Payable Outstanding (DPO)		 97.45 70.12 89.71 89.49 91.00 51.65 53.41 66.49 - 50.87 46.92
Cash Conversion Cycle (CCC)		 -48.66 -24.28 -35.83 -6.51 -7.95 31.57 17.59 39.29 - 71.69 73.04
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 14 21 19 21 14 22 22 30 13 47 51
Invested Capital Turnover		 1.04 0.90 1.22 1.05 1.70 1.54 2.18 2.29 - 2.61 2.97
Increase / (Decrease) in Invested Capital		 11 18 17 8.59 0.28 1.09 3.78 9.01 -0.97 25 29
Enterprise Value (EV)		 422 204 74 88 241 268 453 1,243 - 2,248 1,888
Market Capitalization		 468 243 120 123 296 316 507 1,316 - 2,310 1,963
Book Value per Share		 $0.68 $0.65 $0.69 $0.50 $0.66 $0.60 $0.64 $0.83 $0.80 $0.80 $0.89
Tangible Book Value per Share		 $0.68 $0.65 $0.69 $0.50 $0.66 $0.60 $0.64 $0.83 $0.80 $0.80 $0.89
Total Capital		 60 60 65 56 69 70 77 103 104 109 126
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -46 -39 -46 -35 -55 -48 -54 -73 -90 -62 -75
Capital Expenditures (CapEx)		 5.75 3.90 1.61 1.33 -3.63 0.91 0.72 0.41 2.36 0.63 1.82
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -8.70 -3.18 -6.23 -3.11 -3.60 3.75 5.59 17 18 36 39
Debt-free Net Working Capital (DFNWC)		 37 36 40 32 52 52 60 91 109 98 113
Net Working Capital (NWC)		 37 36 40 32 52 52 60 91 109 98 113
Net Nonoperating Expense (NNE)		 2.91 2.66 3.46 2.97 3.19 2.60 1.60 0.61 6.56 0.37 0.15
Net Nonoperating Obligations (NNO)		 -46 -39 -46 -35 -55 -48 -54 -73 -90 -62 -75
Total Depreciation and Amortization (D&A)		 1.66 1.02 1.04 5.97 2.18 2.23 2.30 2.47 2.51 1.38 1.06
Debt-free, Cash-free Net Working Capital to Revenue		 -96.06% -29.73% -50.15% -17.76% -14.90% 11.31% 12.46% 29.84% - 39.46% 35.45%
Debt-free Net Working Capital to Revenue		 409.42% 334.84% 323.73% 182.72% 213.32% 157.52% 133.32% 155.20% - 108.54% 103.67%
Net Working Capital to Revenue		 409.42% 334.84% 323.73% 182.72% 213.32% 157.52% 133.32% 155.20% - 108.54% 103.67%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.11) ($0.11) ($0.13) ($0.10) ($0.11) ($0.08) ($0.05) ($0.03) ($0.19) ($0.04) ($0.04)
Adjusted Weighted Average Basic Shares Outstanding		 86.20M 90.03M 97.05M 110.41M 101.87M 117.97M 121.78M 126.63M 124.64M 136.95M 143.47M
Adjusted Diluted Earnings per Share		 ($0.11) ($0.11) ($0.13) ($0.10) ($0.11) ($0.08) ($0.05) ($0.03) ($0.19) ($0.04) ($0.04)
Adjusted Weighted Average Diluted Shares Outstanding		 86.20M 90.03M 97.05M 110.41M 101.87M 117.97M 121.78M 126.63M 124.64M 136.95M 143.47M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 91.60M 94.47M 111.05M 105.84M 117.93M 120.55M 125.08M 130.48M 137.02M 141.63M 146.08M
Normalized Net Operating Profit after Tax (NOPAT)		 -6.82 -7.22 -9.05 -7.88 -8.23 -6.77 -4.77 -3.28 -18 -4.68 -3.01
Normalized NOPAT Margin		 -172.94% -309.22% -270.62% -100.28% -77.42% -59.99% -31.65% -15.33% - -16.40% -8.84%
Pre Tax Income Margin		 -246.81% -423.20% -374.20% -138.13% -107.40% -83.05% -42.28% -18.16% - -17.68% -12.63%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Augmented Payout Ratio		 -1.63% -0.89% -1.39% -2.21% -1.69% 0.00% -1.42% 0.00% - 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Amprius Technologies’ financial results show rapid revenue growth and improving gross margins, but the company remains unprofitable and dependent on external financing. Second-quarter 2026 revenue reached $34.0 million, up 120% from $15.1 million in the year-ago quarter and substantially higher than $1.6 million in the second quarter of 2023. Revenue has increased in each comparable second quarter provided.

Profitability is also moving in the right direction. Gross profit rose to $9.3 million in Q2 2026 from $1.3 million a year earlier, lifting the gross margin to approximately 27.3% from 8.9%. The operating loss narrowed to $4.3 million from $6.8 million, while the net loss from continuing operations improved to $3.2 million from $6.4 million. However, a $1.9 million adjustment attributable to common shareholders increased the reported common-stock loss to $5.1 million, or $0.04 per share.

  • Strong top-line momentum: Q2 2026 revenue of $34.0 million was more than double the year-ago figure and over 40 times the Q2 2023 level, indicating significant commercial expansion.
  • Gross-margin improvement: Gross margin expanded to approximately 27.3% from 8.9% in Q2 2025 and negative margins in earlier periods, suggesting better pricing, product mix or manufacturing efficiency.
  • Narrower operating losses: The Q2 2026 operating loss of $4.3 million improved from $6.7 million in Q1 2026, $6.8 million in Q2 2025 and $25.5 million in Q4 2025.
  • Improved operating cash burn: Cash used in operations fell to $2.9 million in Q2 2026 from $37.3 million in Q1 and $4.3 million in Q2 2025. This improvement provides additional flexibility while the company scales production.
  • Substantial liquidity: Cash and equivalents totaled $74.5 million at June 30, 2026, up from $62.4 million at the end of Q1. Current assets of $131.6 million compared with current liabilities of $18.4 million indicate a strong near-term liquidity position.
  • Investment in capacity: Amprius spent $1.8 million on property, plant and equipment during Q2 2026, while net PP&E increased from $10.7 million to $11.7 million sequentially. Continued investment could support future production growth.
  • Financing remains an important cash source: Financing activities provided $16.8 million in Q2 2026 and $8.6 million in Q1. The additional capital helped increase cash, but investors should monitor how much future growth is funded internally versus through capital markets.
  • Working-capital needs are increasing: Accounts receivable rose to $40.7 million from $35.3 million in Q1, while inventory increased to $11.5 million from $8.2 million. These balances may support growth, but they also tie up cash and make collections and inventory management increasingly important.
  • Amprius is still not profitable: The company has reported continuing-operation losses throughout the periods provided, with retained earnings reaching a deficit of $226.6 million at the end of Q2 2026.
  • Shareholder dilution is a persistent risk: Basic weighted-average shares increased to 143.5 million in Q2 2026 from 121.8 million in Q2 2025 and 84.6 million in Q1 2023. Repeated equity financing may support liquidity but reduces each existing shareholder’s ownership percentage.

Operating expenses continue to rise as Amprius invests for growth. Selling, general and administrative expense increased to $9.5 million in Q2 2026 from $6.0 million in Q2 2025, while research and development expense rose to $4.1 million from $2.2 million. These investments may be justified by the company’s revenue growth, but Amprius will need additional scale and gross-profit expansion to cover its cost base and reach sustainable profitability.

Overall, the statements present a mixed picture for investors: commercial traction, improving margins and a stronger cash position are encouraging, while continuing losses, negative operating cash flow, rising working-capital requirements and equity dilution remain significant risks.

09/04/26 05:45 PM ETAI Generated. May Contain Errors.

Amprius Technologies Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Amprius Technologies' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Amprius Technologies' net income appears to be on an upward trend, with a most recent value of -$44.02 million in 2025, rising from -$9.90 million in 2021. The previous period was -$44.67 million in 2024. Check out Amprius Technologies' forecast to explore projected trends and price targets.

Amprius Technologies' total operating income in 2025 was -$46.65 million, based on the following breakdown:
  • Total Gross Profit: $8.26 million
  • Total Operating Expenses: $54.91 million

Over the last 4 years, Amprius Technologies' total revenue changed from $2.77 million in 2021 to $73.01 million in 2025, a change of 2,533.9%.

Amprius Technologies' total liabilities were at $53.08 million at the end of 2025, a 2.8% increase from 2024, and a 1,036.8% increase since 2021.

In the past 4 years, Amprius Technologies' cash and equivalents has ranged from $11.49 million in 2021 to $90.47 million in 2025, and is currently $90.47 million as of their latest financial filing in 2025.

Over the last 4 years, Amprius Technologies' book value per share changed from 0.21 in 2021 to 0.80 in 2025, a change of 277.6%.


Related Companies

Financial statements for NYSE:AMPX last updated on 8/6/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Bezos… DOOMED
A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...
Paradigm Press | Sponsoredtc pixel
Three companies about to leapfrog Nvidia [And transform the entire industry]
AI data centers have a power problem nobody likes to talk about. A single rack of computers can now use more e...
Eagle Publishing | Sponsoredtc pixel
Are you leaving Social Security money on the table?
Most retirement plans still have gaps in them... The quiet ones that don't show up until it's too late to fix....
Money Pickle | Sponsoredtc pixel
Bank of America: 'Digital Dollar Inevitable'
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
Anthropic’s confidential SEC filing — and the public ticker that holds it
Anthropic filed confidentially for an IPO, and its annualized revenue run rate reportedly surged to $65 billio...
The Oxford Club | Sponsoredtc pixel
Near retirement? Buy this stock
On August 9, the Wall Street Journal profiled a unique AI strategy used by three companies. Whitney Tilson of ...
Stansberry Research | Sponsoredtc pixel
Trump’s “new Petrodollar” exposed
Trump has reportedly secured control over 65 billion barrels across 17 Venezuelan oil fields, more than the en...
Porter & Company | Sponsoredtc pixel